MGRX
Mangoceuticals, Inc. Common Stock
NASDAQ: MGRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$0.34
+2.56% today
Updated 2026-04-30
Market cap
$6.79M
P/E ratio
—
P/S ratio
14.88x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$0 – $3
Volume
15.5M
Mangoceuticals, Inc. Common Stock (MGRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-17520.00 | $-1.35M | $-7.00M | $-4.86M | $-5.85M |
| Capital expenditures | $43102.00 | $43102.00 | $3519.00 | $0.00 | $5.00 |
| Depreciation | $3863.00 | $3863.00 | $24889.00 | $731469.00 | — |
| Stock-based comp | — | $234088.00 | $624463.00 | $248682.00 | $1.17M |
| Free cash flow | $-60622.00 | $-1.39M | $-7.00M | $-4.86M | $-5.85M |
| Investing cash flow | $-43102.00 | $-43102.00 | $-3519.00 | $65000.00 | — |
| Financing cash flow | $40070.00 | $2.05M | $7.06M | $4.13M | — |
| Dividends paid | — | — | — | $802109.00 | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |